Related Experiment Videos
Tigliane-type phorbols stimulate human melanocyte proliferation: potentially safer agents for melanocyte culture
1Laboratory for Investigative Dermatology, Rockefeller University, NY, NY 10021-6399.
Abstract:
Previous studies have established that some phorbol compounds that are active in binding to protein kinase C (PKC) are also strong mitogens for human melanocytes in culture. Structure/activity studies on tigliane class phorbol compounds, which lack an oxygen at the 12 position, have shown that tumor-promoting activity can be diminished or abolished though retaining other biologic activities of phorbol compounds, including the ability to activate PKC. In this study, two tigliane class phorbol derivates [12 deoxyphorbol, 13 isobutyrate (DPIB) and 12 deoxyphorbol, 13 phenylacetate (DPPA)] were studied for their ability to stimulate melanocyte proliferation in a serum-free culture system based on MCDB 153 medium. Compared to the activity of phorbol 12-O-myristate, 13 acetate (PMA), a widely used tumor-promoting phorbol derivative, DPIB and DPPA were effective mitogens for human melanocytes. The importance of PKC activation in mitogenic modulation of human melanocytes is further supported by the stereospecific mitogenic activity of (-)Indolactam V, a PKC-activating compound structurally unrelated to phorbols. The use of the tigliane type phorbols DPIB and DPPA to stimulate growth of human melanocytes may provide safer compounds for laboratory or patient studies and may also provide further insights into the role of PKC activation in human melanocyte biology.
Insights
Two novel phorbol derivatives, DPIB and DPPA, effectively stimulate human melanocyte proliferation by activating protein kinase C (PKC). These compounds offer a safer alternative for studying melanocyte growth and PKC
Area of Science:
- Cell Biology
- Biochemistry
- Dermatology
Background:
- Phorbol compounds activate protein kinase C (PKC) and stimulate human melanocyte proliferation.
- Tigliane class phorbols, lacking oxygen at the 12 position, can retain biologic activities while having diminished tumor-promoting potential.
- Understanding melanocyte mitogenesis is crucial for skin biology and potential therapeutic applications.
Purpose of the Study:
- To investigate the mitogenic potential of tigliane class phorbol derivatives, 12 deoxyphorbol, 13 isobutyrate (DPIB) and 12 deoxyphorbol, 13 phenylacetate (DPPA), on human melanocytes.
- To assess the role of protein kinase C (PKC) activation in mediating melanocyte proliferation.
- To explore safer alternatives to existing phorbol derivatives for research and clinical use.
Main Methods:
- Human melanocytes were cultured in a serum-free MCDB 153 medium.
- The mitogenic effects of DPIB and DPPA were compared to phorbol 12-O-myristate, 13 acetate (PMA).
- The stereospecific mitogenic activity of (-)Indolactam V was evaluated to confirm the role of PKC.
Main Results:
- Both DPIB and DPPA demonstrated significant mitogenic activity, stimulating human melanocyte proliferation.
- These tigliane derivatives were effective mitogens, comparable to PMA, in the tested culture system.
- The study confirmed the involvement of PKC activation in the mitogenic response of human melanocytes.
Conclusions:
- Tigliane class phorbols DPIB and DPPA are potent mitogens for human melanocytes.
- These compounds represent potentially safer alternatives for laboratory and clinical investigations into melanocyte biology.
- The findings reinforce the critical role of protein kinase C (PKC) in regulating human melanocyte growth.